抑制醣化終產物對慢性腎衰竭大鼠動脈硬化之影響

莊曜禎 - 2012 - 120.107.56.30
慢性腎臟病的病程持續進展, 最後終究會演變為慢性腎衰竭或末期腎臟疾病,
並會造成比正常人多出十到二十倍的心血管併發症發生率. 在慢性腎衰竭的患者中 …

抑制醣化終產物對慢性腎衰竭大鼠動脈硬化之影響

YC Chuang - 臺灣大學生理學研究所學位論文, 2012 - airitilibrary.com
Chronic kidney diseases always develop to chronic renal failure (CRF) or end-stage renal
diseases eventually, and associated with 10 to 20-fold increased incidence in …

Effects of olmesartan on arterial stiffness in rats with chronic renal failure

YC Chuang, MS Wu, YK Su, KM Fang - Cardiovascular Diabetology, 2012 - Springer
Background It has been suggested that the antioxidant properties of olmesartan (OLM), an
angiotensin II type 1 receptor (AT 1 R) blocker, contribute to renal protection rather than …

Chronic treatment with angiotensin‐(1‐7) improves renal endothelial dysfunction in apolipoproteinE‐deficient mice

J Stegbauer, SA Potthoff, I Quack… - British journal of …, 2011 - Wiley Online Library
BACKGROUND AND PURPOSE ApolipoproteinE‐deficient [apoE (−/−)] mice, a model of
human atherosclerosis, develop endothelial dysfunction caused by decreased levels of nitric …

[HTML][HTML] Advanced glycation end products inhibit de novo protein synthesis and induce TGF-β overexpression in proximal tubular cells

SI Yamagishi, Y Inagaki, T Okamoto, S Amano… - Kidney international, 2003 - Elsevier
Advanced glycation end products inhibit de novo protein synthesis and induce TGF-β
overexpression in proximal tubular cells. Background We have shown previously that OPB …

Advanced glycosylation end products increase cellular inflammation in atherosclerotic plaques

W Zhang, F Hou, S Liu, Z Guo… - Chinese Journal of …, 1997 - pesquisa.bvsalud.org
Objective To test the hypothesis that advanced glycosylation end products (AGEs) increase
cellular inflammation in atherosclerotic plaques. Methods Fifty rabbits were randomly …

Advanced glycation end products (AGEs) increase renal lipid accumulation: a pathogenic factor of diabetic nephropathy (DN)

Y Yuan, H Sun, Z Sun - Lipids in Health and Disease, 2017 - Springer
Background Advanced glycation end products (AGEs) are pathogenic factors of diabetic
nephropathy (DN), causing renal damage in various ways. The aim of this study is to …

Advanced glycation end products in chronic kidney disease: pathogenic role and preventive strategy

Y Ying, CAI Guang-Yan - Jie Fang Jun Yi Xue Za Zhi, 2020 - search.proquest.com
Advanced glycation end products (AGE) are stable compounds produced by spontaneous
non-enzymatic reaction between reducing sugars and proteins, and have been proven …

Olmesartan 能延緩果糖餵食大鼠之動脈硬化及心肌肥厚

余芝瑤 - 臺灣大學生理學研究所學位論文, 2009 - airitilibrary.com
背景: 大量增加果糖攝取量會導致高血壓, 胰島素阻抗及脂質異常, 這三者對於心血管疾病皆為已
確立的危險因子. 果糖亦可能造成醣化最終產物(advanced glycation end-product, AGE) 形成 …

[引用][C] GLYCOBIOLOGY AND EXTRACELLULAR MATRICES-Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth …

S Yamagishi, Y Inagaki, T Okamoto… - Journal of Biological …, 2002 - Baltimore [etc.]